In August 2017 – after concluding a distribution agreement with the French company Macopharma – Dripmate shipped its first part-delivery, which is now on the French market.
The distribution agreement grants Macopharma exclusivity to distribute Dripmate products in France, Great Britain, Belgium, Holland, Luxembourg and Austria.
CEO Morten Mernøe comments:
“Prior to our first delivery, Macopharma representatives visited us and our subcontractors and they were very pleased with the quality of our setup and the product itself. Dripmate targets the application range between the usual IV treatment and the very expensive pump treatment which so far have been the only two options. Macopharma supplies products to more than 3,000 hospitals, several of which have more than 1,000 beds. By comparison, in Denmark there are approx. 60 hospitals”.
The first order, which will be delivered continuously over 1-2 months, has a value of DKK 3.6 million.
Macopharma is a distributor company with more than 2,500 employees and a turnover of more than EUR 186 million in 2016.